Inventor
BAROUCH DAN H
US26 patents
⚠️ This page may combine multiple inventors who share the name “BAROUCH DAN H”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
BETH ISRAEL DEACONESS MEDICAL CT INC
22 patentsUS10781427B2Sep 22, 2020
Recombinant adenoviruses and use thereof
BETH ISRAEL DEACONESS MEDICAL CT INC15 citations90
US9670253B2Jun 6, 2017
Antiviral vaccines with improved cellular immunogenicity
BETH ISRAEL DEACONESS MEDICAL CT INC4 citations83
US10106781B2Oct 23, 2018
Recombinant adenoviruses and use thereof
BETH ISRAEL DEACONESS MEDICAL CT INC5 citations80
US9932370B2Apr 3, 2018
Stabilized mosaic human immunodeficiency virus type 1 (HIV-1) GP140 envelope (ENV) trimers
BETH ISRAEL DEACONESS MEDICAL CT INC10 citations80
US10376583B2Aug 13, 2019
Human immunodeficiency virus therapies utilizing N332-glycan-dependent antibodies and a reservoir activator
BETH ISRAEL DEACONESS MEDICAL CT INC4 citations72
US11331386B2May 17, 2022
Antiviral vaccines with improved cellular immunogenicity
BETH ISRAEL DEACONESS MEDICAL CT INC0 citations62
US11202830B2Dec 21, 2021
Human immunodeficiency virus therapies utilizing N332-glycan-dependent antibodies in subjects with low viral loads
BETH ISRAEL DEACONESS MEDICAL CT INC0 citations62
USRE50753EJan 20, 2026
Recombinant adenoviruses and use thereof
BETH ISRAEL DEACONESS MEDICAL CT INC0 citations59
US11059863B2Jul 13, 2021
Stabilized human immunodeficiency virus (HIV) envelope (ENV) trimer vaccines and methods of using same
BETH ISRAEL DEACONESS MEDICAL CT INC0 citations58
US12459989B2Nov 4, 2025
Antibody therapies for human immunodeficiency virus (HIV)
BETH ISRAEL DEACONESS MEDICAL CT INC0 citations57
US12312382B2May 27, 2025
Recombinant adenoviruses and uses thereof
BETH ISRAEL DEACONESS MEDICAL CT INC0 citations57
US11773142B2Oct 3, 2023
Recombinant adenoviruses and uses thereof
BETH ISRAEL DEACONESS MEDICAL CT INC0 citations57
US11230572B2Jan 25, 2022
Signature-based human immunodeficiency virus (HIV) envelope (Env) trimer vaccines and methods of using the same
BETH ISRAEL DEACONESS MEDICAL CT INC1 citations57
US10611801B2Apr 7, 2020
Compositions and methods for preventing and treating Zika virus infection
BETH ISRAEL DEACONESS MEDICAL CT INC1 citations55
US10772952B2Sep 15, 2020
Antiviral vaccines with improved cellular immunogenicity
BETH ISRAEL DEACONESS MEDICAL CT INC0 citations51
US10426831B2Oct 1, 2019
Antiviral vaccines with improved cellular immunogenicity
BETH ISRAEL DEACONESS MEDICAL CT INC0 citations51
US10463729B2Nov 5, 2019
Biochemically stabilized HIV-1 env trimer vaccine
BETH ISRAEL DEACONESS MEDICAL CT INC0 citations49
US10307478B2Jun 4, 2019
Biochemically stabilized HIV-1 Env trimer vaccine
BETH ISRAEL DEACONESS MEDICAL CT INC0 citations49
US10160788B2Dec 25, 2018
Stabilized human immunodeficiency virus (HIV) envelope (ENV) trimer vaccines and methods of using same
BETH ISRAEL DEACONESS MEDICAL CT INC0 citations48
US9950060B2Apr 24, 2018
Biochemically stabilized HIV-1 Env trimer vaccine
BETH ISRAEL DEACONESS MEDICAL CT INC0 citations47
US11845788B2Dec 19, 2023
Antibody therapies for human immunodeficiency virus (HIV)
BETH ISRAEL DEACONESS MEDICAL CT INC0 citations45
US10716845B2Jul 21, 2020
Stabilized human immunodeficiency virus (HIV) clade C envelope (Env) trimer vaccines and methods of using same
BETH ISRAEL DEACONESS MEDICAL CT INC0 citations44
JANSSEN PHARMACEUTICALS INC
2 patentsUS11498944B2Nov 15, 2022
Compositions and methods for preventing and treating coronavirus infection—SARS-CoV-2 vaccines
JANSSEN PHARMACEUTICALS INC10 citations81
US11384122B2Jul 12, 2022
Compositions and methods for preventing and treating coronavirus infection—SARS-CoV-2 vaccines
JANSSEN PHARMACEUTICALS INC2 citations68